Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
6,511
Total Claims
$669K
Drug Cost
542
Beneficiaries
$1,235
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-65%
Opioid rate vs peers
0.8% vs 2.2% avg
-13%
Cost per patient vs peers
$1,235 vs $1,411 avg
+27%
Brand preference vs peers
13.5% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.8%
Opioid Rate
51
Opioid Claims
$312
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 874 claims · $545K
Generic: 5,608 claims · $124K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 61 | $100K |
| Apixaban | 84 | $76K |
| Empagliflozin | 31 | $55K |
| Rivaroxaban | 28 | $46K |
| Fluticasone/Umeclidin/Vilanter | 26 | $41K |
| Sitagliptin Phosphate | 14 | $20K |
| Insulin Aspart | 11 | $15K |
| Budesonide/Formoterol Fumarate | 15 | $11K |
| Fluticasone Propion/Salmeterol | 15 | $9,462 |
| Insulin Degludec | 11 | $8,747 |
| Insulin Glargine,hum.Rec.Anlog | 17 | $8,696 |
| Linaclotide | 13 | $7,021 |
| Tiotropium Br/Olodaterol Hcl | 12 | $7,007 |
| Levothyroxine Sodium | 423 | $5,419 |
| Insulin Glargine,hum.Rec.Anlog | 18 | $4,906 |
Prescribing Profile
Patient Profile
74
Avg Age
47%
Female
1.14
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About